{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:44:07Z","timestamp":1789055047056,"version":"build-2803163510"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The French National Agency for Medicines and Health Products Safety implemented in 2021 a nationwide experimentation for medical cannabis (MC), designed to assess the feasibility of implementing a new public health policy. A dedicated registry was established to support the notification of adverse drug reactions (ADRs). The objective of this study was to describe the safety data collected during the first 3\u2009years of experimentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Data related to MC use were extracted from the registry and the French pharmacovigilance and addictovigilance database between March 26, 2021, and March 31, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Among the 3164 included patients, at least one ADR was reported in 1186 patients, including 81 patients (3%) with serious ADRs (SADRs). The most common ADRs were neurological (37.2%), gastrointestinal (16.9%), and psychiatric (15.2%). Among SADRs, six cases of acute coronary syndromes were reported, along with eight cases of suicidal thoughts including one suicide attempt. Half of these psychiatric events occurred in patients without a prior psychiatric history, and no cases of psychosis were documented. Regarding addictovigilance, only 12 ADRs were analyzed: seven withdrawal syndromes, three cases of tolerance, and two cases of THC\u2010containing inflorescence misuse, including one case of MC use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>During the experimentation, 3% of patients treated with MC experienced at least one serious ADR. The safety profile was dominated by neurological, gastrointestinal, and psychiatric ADRs. Only one case of MC misuse was identified with inflorescences. This study is observational and non\u2010comparative and cannot provide a comprehensive assessment of the risk associated with MC use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/fcp.70074","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T08:13:55Z","timestamp":1772957635000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance\/Addictovigilance System From 2021 to 2024"],"prefix":"10.1111","volume":"40","author":[{"given":"C\u00e9cile","family":"Chevallier","sequence":"first","affiliation":[{"name":"Centre d\u2019Evaluation et d\u2019Information sur la Pharmacod\u00e9pendance Hospices Civils de Lyon  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Batisse","sequence":"additional","affiliation":[{"name":"Centre d\u2019Evaluation et d\u2019Information sur la Pharmacod\u00e9pendance Assitance publique \u2013 Hopitaux de Paris  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Monzon","sequence":"additional","affiliation":[{"name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9  Saint\u2010Denis France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Richard","sequence":"additional","affiliation":[{"name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9  Saint\u2010Denis France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie M\u00e9dicale CHU de Clermont\u2010Ferrand  Clermont\u2010Ferrand France"},{"name":"Fondation Analgesia, Observatoire Fran\u00e7ais de la Douleur et des Antalgiques (OFDA) \u2010 UMR Inserm 1107 \u2013 NeuroDol, Facult\u00e9 de M\u00e9decine  Clermont\u2010Ferrand France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance de Clermont\u2010Ferrand, CHU de Clermont\u2010Ferrand  Clermont\u2010Ferrand France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Gaboriau","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance de Lille, CHU de Lille  Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Ferey","sequence":"additional","affiliation":[{"name":"Centre d\u2019Evaluation et d\u2019Information sur la Pharmacod\u00e9pendance, CHU de Caen  Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Chretien","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Regional Pharmacovigilance Centre, CHU Caen  Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Fedrizzi","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance de Caen, CHU de Caen  Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-9083","authenticated-orcid":false,"given":"Marine","family":"Auffret","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance de Lyon Hospices Civils de Lyon  Lyon France"},{"name":"UMR 5558 Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive, Universit\u00e9 Lyon 1  Villeurbanne France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"ANSM \u201cDossier th\u00e9matique \u2010 cannabis \u00e0 usage m\u00e9dical \u201d accessed April 29 2025 https:\/\/ansm.sante.fr\/dossiers\u2010thematiques\/cannabis\u2010a\u2010usage\u2010medical."},{"key":"e_1_2_11_3_1","unstructured":"ANSM \u201cComit\u00e9 Suivi de l'exp\u00e9rimentation fran\u00e7aise de l'usage m\u00e9dical du cannabis 23\/11\/2023 \u201d Disponible Sur accessed November 18 2025 https:\/\/ansm.sante.fr\/evenements\/comite\u2010suivi\u2010de\u2010lexperimentation\u2010francaise\u2010de\u2010lusage\u2010medical\u2010du\u2010cannabis\u201025."},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.09.005"},{"key":"e_1_2_11_5_1","unstructured":"ANSM \u201cBonnes pratiques de pharmacovigilance \u201d accessed November 9 2025 https:\/\/ansm.sante.fr\/documents\/reference\/bonnes\u2010pratiques\u2010de\u2010pharmacovigilance."},{"key":"e_1_2_11_6_1","unstructured":"European Medecine Agency \u201cSerious Adverse Reaction \u201d accessed April 29 2025 https:\/\/www.ema.europa.eu\/en\/glossary\/serious\u2010adverse\u2010reaction#:~:text=An%20adverse%20reaction%20that%20results or%20is%20a%20birth%20defect."},{"key":"e_1_2_11_7_1","unstructured":"MEDDRA \u201cMEDDRA \u2013 Basics \u201d accessed April 29 2025 https:\/\/www.meddra.org\/basics."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386\u2010020\u20100667\u20102"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1634086"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012182.pub2"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.09.015"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2017.0891"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071178"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26206257"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010100"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9126"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003524"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116697"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.115047"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000883"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883\u2010017\u20100663\u20100"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl\u20102024\u2010325429"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12872\u2010021\u201002229\u20106"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad834"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010022\u201001146\u20107"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2023.09.004"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.09.038"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.70028"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000442"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2023.05.003"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.030"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1935879"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.02.003"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437211060597"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2023.2183841"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.004"},{"key":"e_1_2_11_37_1","unstructured":"Drogues et addictions chiffres cl\u00e9s 2025|OFDTaccessed November 18 2025 https:\/\/www.ofdt.fr\/publication\/2025\/drogues\u2010et\u2010addictions\u2010chiffres\u2010cles\u20102025\u20102474."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2020.02.010"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120986393"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2040"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70074","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/fcp.70074","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:33:25Z","timestamp":1774413205000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.70074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/fcp.70074"],"URL":"https:\/\/doi.org\/10.1111\/fcp.70074","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2025-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70074"}}